The invention provides isolated dendritic cells genetically modified to express a selectin polypeptide, optionally treated with activated platelets or membrane microparticles thereof. The invention also provides isolated platelet modified dendritic cells. Methods for delivering the modified dendritic cells to peripheral lymph nodes and methods for using the modified dendritic cells to stimulate immune responses also are provided. Vaccine compositions containing the modified dendritic cells also are provided.

 
Web www.patentalert.com

< Method of purifying oocysts using enzymatic digestion of fecal debris

< Materials and methods for the modification of plant lignin content

> Proteins related to schizophrenia and uses thereof

> Assays for sensory modulators using a sensory cell specific G-protein beta subunit
~ 00201